Incidence of infections due to Escherichia coli strains producing extended spectrum betalactamase, in the Zou/Collines Hospital Centre (CHDZ/C) in Benin;Incidence d'infections liées à Escherichia coli producteur de bêta lactamase à spectre élargi au Centre hospitalier départemental du Zou et Collines au Bénin

Medecine et Maladies Infectieuses

Volumn 37, Issue 11, 2007, Pages 746-752

  Ahoyo, A T ^a   Baba Moussa, L ^a   Anago, A E ^b   Avogbe, P ^a   Missihoun, T D ^a   Loko, F ^b   Prevost G ^c   Sanni, A ^a   Dramane, K ^a  

^a UNIVERSITY OF ABOMEY CALAVI   (Benin)

^b Ecole Polytechnique d'Abomey Calavi   (Benin)

^c UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Escherichia coli; Extended spectrum betalactamase

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZTREONAM; CEFAZOLIN; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; PIPERACILLIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL INFECTION; BACTERIAL STRAIN; BENIN; CONTROLLED STUDY; ESCHERICHIA COLI; HOSPITAL INFECTION; HUMAN; MAJOR CLINICAL STUDY; MORBIDITY; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION;

ANTI-BACTERIAL AGENTS; BENIN; BETA-LACTAMASES; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HUMANS; INCIDENCE; MICROBIAL SENSITIVITY TESTS; POLYMERASE CHAIN REACTION;

EID: 36348961875     PISSN: 0399077X     EISSN: 17696690     Source Type: Journal    
DOI: 10.1016/j.medmal.2007.03.004     Document Type: Article

References (29)

1. Cooke E.M. Escherichia coli and man (1973), Churchill Living Stone, London
2. Lucet J.C., Chevret S., Decre D., et al. Outbreak of multiresistant enterobacteriaceae in an intensive care unit: epidemiology and risk factors for acquisition. Clin. Infect. Dis. 22 (1996) 430-436
3. Bradford P.A. Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin. Microbiol. Rev. 14 (2001) 933-951
4. Knothe H., Shah P., Krcmery V., Antal M., and Mitsuhashi S. Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection 11 (1983) 315-317
5. Patterson J.E. Antibiotic utilization: is there an effect on antimicrobial resistance. Chest 119 (2001) 426-430
6. Masterton R., Drusano G., Paterson D.L., and Park G. Appropriate antimicrobial treatment in nosocomial infections-the clinical challenges. J. Hosp. Infect. 55 (2003) 1-12
7. Lucet J.-C., Decré D., Fichelle A., Joly-Guillou M.-L., Pernet M., Deblangy C., et al. Control of a prolonged outbreak of extended-spectrum β-lactamase-producing enterobacteriaceae in a university hospital. Clin. Infect. Dis. 20 (1999) 1411-1418
8. Rodríguez-Baño J., Navarro M.D., Romero L., Martínez-Martínez L., Muniain M.A., Perea E.J., et al. Epidemiology and clinical features of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in non-hospitalized patients. J. Clin. Microbiol. 42 (2004) 1089-1094
9. Tietz A., Francioli P., Widmer A.F., et al. Bêtalactamases à spectre étendu : implications pour l'hygiène hospitalière. Swiss noso (2004) (11, Numéro 4, article 2)
10. Dubois S.K., Marriott M.S., and Amyes S.G. TEM- and SHV-derived extended-spectrum beta-lactamases: relationship between selection, structure and function. J. Antimicrob. Chemother. 35 (1995) 7-22
11. Heritage J., M'Zali F.H., Gascoyne-Binzi D., and Hawkey P.M. Evolution and spread of SHV extended spectrum β-lactamases in Gram-negative bacteria. J. Antimicrob. Chemother. 44 (1999) 309-318
12. Stobberingh E.E., Arends J., Hoogkamp-Korstanje J.A.A., Goessens W.H.F., Visser M.R., Buiting A.G.M., et al. Occurrence of extended-spectrum beta-lactamases in Dutch hospitals. Infection 27 (1999) 348-354
13. Pitout J.D.D., Thomson K.S., Hanson N.D., Ehrhardt A.F., Moland E.S., and Sanders C.C. β-Lactamases responsible for resistance to expanded-spectrum cephalosporins in Klebsiella pneumoniae, Escherichia coli, and Proteus mirabilis isolates recovered in South Africa. Antimicrob. Agents Chemother. 42 (1998) 1350-1354
14. Gangoué-Piéboji J., Bedenic B., Koulla-Shiro S., Randegger C., Adiogo D., et al. Extended-spectrum-β-lactamase-producing Enterobacteriaceae in Yaounde, Cameroon. J. Clin. Microbiol. 43 (2005) 3273-3277
15. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing, 12th informational supplement (2002), NCCLS document M100-S12, Wayne, Pa
16. Jarlier V., Nicolas M., Fournier G., and Philippon A. Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev. Infect. Dis. 10 (1988) 867-878
17. Thomson K.S., and Sanders C.C. Detection of extended-spectrum β-lactamases in members of the family Enterobacteriaceae: comparison of the double-disk and three-dimensional tests. Antimicrob. Agents Chemother. 36 (1992) 1877-1882
18. Ausubel F.M., Brent R., Kingston R.E., Moore D.D., Seidman J.G., Smith J.A., et al. Current protocols in molecular biology (1994), John Wiley & Sons, Inc., Chichester, United Kingdom
19. Tzelepi E., Giakkoupi P., Sofianou D., Loukova V., Kermeroglou A., and Tsakris A. Detection of extended-spectrum β-lactamases in clinical isolates of Enterobacter cloacae and Enterobacter aerogenes. J. Clin. Microbiol. 38 (2000) 542-546
20. Kariuki S., Corkill J.E., Revathi G., Musoke R., and Hart C.A. Molecular characterization of a novel plasmid-encoded cefotaximase (CTX-M-12) found in clinical Klebsiella pneumoniae isolates from Kenya. Antimicrob. Agents Chemother. 45 (2001) 2141-2143
21. Faustine N, Roland J, Stig H, Willy U, Nina L. Extended spectrum-lactamases among Gram-negative bacteria of nosocomial origin from an Intensive Care Unit of a tertiary health facility in Tanzania. BMC Infect. Dis. 2005;5:86 10.1186/1471-2334-5-86.
22. Ho P.L., Tsang D.N.C., Que T.L., Ho M., and Yuen K.Y. Comparison of screening methods for detection of extended-spectrum β-lactamases and their prevalence among Escherichia coli and Klebsiella species in Hong Kong. APMIS 108 (2000) 237-240
23. Bjørn B., Roland J., Manji K.P., Tamim B.S., Mwakagile D.S.M., et al. High rate of fatal cases of paediatric septicaemia caused by Gram-negative bacteria with extended-spectrum beta-lactamases in Dar es Salaam, Tanzania. J. Clin. Microbiol. 43 (2005) 745-749
24. Tolun V., Kucukbasmaci O., Torumkuney-Akbulut D., Catal C., Ang-Kucuker M., and Ang O. Relationship between ciprofloxacin resistance and extended-spectrum beta-lactamase production in Escherichia coli and Klebsiella pneumoniae strains. Clin. Microbiol. Infect. 10 (2004) 72-75
25. Alhambra A., Cuadros J.A., Cacho J., Gomez-Garces J.L., and Alos J.I. In vitro susceptibility of recent antibiotic-resistant urinary pathogens to ertapenem and 12 other antibiotics. J. Antimicrob. Chemother. 53 (2004) 1090-1094
26. Martinez-Martinez L., Pascual A., and Jacoby G.A. Quinolone resistance from a transferable plasmid. Lancet 351 (1998) 797-799
27. Pfaller M.A., and Herwaldt L.A. The clinical microbiology laboratory and infection control: emerging pathogens, antimicrobial resistance, and new technology. Clin. Infect. Dis. 25 (1997) 858-870
28. Eveillard M., Eb F., Tramier B., Schmit J.L., Lescure F.X., Biendo M., et al. Evaluation of the contribution of isolation precautions in prevention and control of multi-resistant bacteria in a teaching hospital. J. Hosp. Infect. 47 (2001) 116-124
29. Paterson D.L., Mulazimoglu L., Casellas J.M., Ko W.C., Goossens H., Von Gottberg A., et al. Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Klebsiella pneumoniae isolates causing bacteremia. Clin. Infect. Dis. 30 (2000) 473-478